Approval · Notice of Compliance 5501 · 1994
SELEPEN: Notice of Compliance 5501
Issued November 21, 1994
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5501
- Date
- November 21, 1994
- Company
- Fujisawa Canada Inc.Markham, Ontario, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Trace element additive
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SELEPEN | 02139316 | Cancelled Post Market |
Medicinal ingredients
- SELENIUM 40 MCG per ML